Antibiotic efficacy in the complex infection environment

Current Opinion in Microbiology

Volumn 42, Issue , 2018, Pages 19-24

  Radlinski, L ^a   Conlon, B P ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENVIRONMENT; HOST PATHOGEN INTERACTION; HUMAN; INFECTION; NONHUMAN; REVIEW; ANTIBIOTIC RESISTANCE; DRUG EFFECT; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; ORGANISMAL INTERACTION; PHYSIOLOGY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DRUG RESISTANCE, MICROBIAL; HOST-PATHOGEN INTERACTIONS; HUMANS; MICROBIAL INTERACTIONS; MICROBIAL SENSITIVITY TESTS; TREATMENT OUTCOME;

EID: 85030717848     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2017.09.007     Document Type: Review

References (50)

1. Payne, D.J., Gwynn, M.N., Holmes, D.J., Pompliano, D.L., Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6 (2007), 29–40.
2. Silver, L.L., Challenges of antibacterial discovery. Clin Microbiol Rev 24 (2011), 71–109.
3. Smith, A.L., Fiel, S.B., Mayer-Hamblett, N., Ramsey, B., Burns, J.L., Susceptibility testing of Pseudomonas aeruginosa isolates and clinical response to parenteral antibiotic administration: lack of association in cystic fibrosis. Chest 123 (2003), 1495–1502.
4. Gillham, M.I., et al. Variable antibiotic susceptibility in populations of Pseudomonas aeruginosa infecting patients with bronchiectasis. J Antimicrob Chemother 63 (2009), 728–732.
5. Bigger, J.W., Treatment of staphylococcal infections with penicillin. Lancet ii (1944), 497–500.
6. Keren, I., Kaldalu, N., Spoering, A., Wang, Y., Lewis, K., Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230 (2004), 13–18 By comparing antibiotic tolerance in E. coli, P. aeruginosa, and S. aureus during lag, early exponential and late exponential growth, these authors demonstrate that the formation of persister cells is dependent on a population's stage of growth.
7. Sakoulas, G., et al. Ampicillin enhances daptomycin- and cationic host defense peptide-mediated killing of ampicillin- and vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 56 (2012), 838–844 These authors demonstrate that ampicillin reduces the overall net positive charge of vancomycin-resistant Enterococcus faecium resulting in increased bactericidal activity of cationic peptides.
8. Sakoulas, G., et al. Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus. J Mol Med (Berl) 92 (2014), 139–149.
9. Lin, L., et al. Azithromycin synergizes with cationic antimicrobial peptides to exert bactericidal and therapeutic activity against highly multidrug-resistant gram-negative bacterial pathogens. EBioMedicine 2 (2015), 690–698 In this study the authors show that azithromycin synergizes with host cationic antimicrobial peptides to exhibit potent bactericidal activity against multi-drug resistant Pseudomonas aeruginosa, Klebsiella pneumoniae and Acinetobacter baumannii.
10. Kumaraswamy, M., et al. Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia. J Antimicrob Chemother 71 (2016), 1264–1269 This study highlights the failings of common antibiotic susceptibility testing towards identifying all determinants of antibiotic efficacy in the infection site.
11. Ouadrhiri, Y., Scorneaux, B., Sibille, Y., Tulkens, P.M., Mechanism of the intracellular killing and modulation of antibiotic susceptibility of Listeria monocytogenes in THP-1 macrophages activated by gamma interferon. Antimicrob Agents Chemother 43 (1999), 1242–1251.
12. Barcia-Macay, M., Seral, C., Mingeot-Leclercq, M.P., Tulkens, P.M., Van Bambeke, F., Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob Agents Chemother 50 (2006), 841–851.
13. Wendte, J.M., Ponnusamy, D., Reiber, D., Blair, J.L., Clinkenbeard, K.D., In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis. Antimicrob Agents Chemother 55 (2011), 3752–3757.
14. Band, V.I., et al. Antibiotic failure mediated by a resistant subpopulation in Enterobacter cloacae. Nat Microbiol, 1, 2016, 16053 Using a mouse model, the authors show that the action of the innate immune response leads to a subpopulation of Enterobacter cloacae that is highly resistant to the last-line antibiotic colistin. Importantly, this resistence avoids detection during standard MIC testing.
15. Helaine, S., et al. Internalization of Salmonella by macrophages induces formation of nonreplicating persisters. Science 343 (2014), 204–208 Using single-cell fluoresence dilution analysis, the authors demonstrate that macophage phagocytosis of Salmonella induces a non-replicative persister state that is tolerant to antibiotic killing.
16. McCollister, B.D., Hoffman, M., Husain, M., Vazquez-Torres, A., Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake. Antimicrob Agents Chemother 55 (2011), 2189–2196.
17. Dorr, T., Lewis, K., Vulic, M., SOS response induces persistence to fluoroquinolones in Escherichia coli. PLoS Genet, 5, 2009, e1000760 Here the authors show that activation of the SOS response following fluoroquinolone exposure induces perister cell formation in Esherichia coli. This is an early example of environmental factors inducing perister cell formation.
18. Lewis, K., Persister cells. Annu Rev Microbiol 64 (2010), 357–372.
19. Conlon, B.P., Staphylococcus aureus chronic and relapsing infections: evidence of a role for persister cells: an investigation of persister cells, their formation and their role in S. aureus disease. Bioessays 36 (2014), 991–996.
20. Sorg, R.A., et al. Collective resistance in microbial communities by intracellular antibiotic deactivation. PLoS Biol, 14, 2016, e2000631 The authors show that a chloramphenicol resistant population can deactivate chloramphenicol in vivo facilitating the growth of an apparently chloramphenicol sensitive strain.
21. Medaney, F., Dimitriu, T., Ellis, R.J., Raymond, B., Live to cheat another day: bacterial dormancy facilitates the social exploitation of beta-lactamases. ISME J 10 (2016), 778–787.
22. Hoffman, L.R., et al. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 103 (2006), 19890–19895 The authors show that the presence of Pseudomonas aeruginosa induces transient resistance to tobramycin in Staphylococcus aureus by surpressing growth via the secondary metabolite HQNO.
23. Orazi, G., O'Toole, G.A., Pseudomonas aeruginosa alters Staphylococcus aureus sensitivity to vancomycin in a biofilm model of cystic fibrosis infection. MBio, 8, 2017.
24. Leung, V., Levesque, C.M., A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J Bacteriol 194 (2012), 2265–2274.
25. Moker, N., Dean, C.R., Tao, J., Pseudomonas aeruginosa increases formation of multidrug-tolerant persister cells in response to quorum-sensing signaling molecules. J Bacteriol 192 (2010), 1946–1955.
26. Vega, N.M., Allison, K.R., Samuels, A.N., Klempner, M.S., Collins, J.J., Salmonella typhimurium intercepts Escherichia coli signaling to enhance antibiotic tolerance. Proc Natl Acad Sci U S A 110 (2013), 14420–14425.
27. Armbruster, C.E., et al. Indirect pathogenicity of Haemophilus influenzae and Moraxella catarrhalis in polymicrobial otitis media occurs via interspecies quorum signaling. MBio, 1, 2010.
28. Costerton, J.W., et al. Bacterial biofilms in nature and disease. Annu Rev Microbiol 41 (1987), 435–464.
29. Kean, R., et al. Candida albicans mycofilms support Staphylococcus aureus colonization and enhances miconazole resistance in dual-species interactions. Front Microbiol, 8, 2017, 258 Through in vitro and in vivo study, the authors demonstrate that during co-infection with Staphylococcus aureus, Candida albicans extracellular matrix production supports dual species bioflim formation with decreased susceptibility of S. aureus to miconazole killing.
30. Tunney, M.M., et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 177 (2008), 995–1001.
31. Sen, C.K., Wound healing essentials: let there be oxygen. Wound Repair Regen 17 (2009), 1–18.
32. Park, M.K., Myers, R.A., Marzella, L., Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses. Clin Infect Dis 14 (1992), 720–740.
33. White, B.K., et al. Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualties. Diagn Microbiol Infect Dis 84 (2016), 144–150.
34. Freeman, C.D., Klutman, N.E., Lamp, K.C., Metronidazole. A therapeutic review and update. Drugs 54 (1997), 679–708.
35. Bryan, L.E., Van Den Elzen, H.M., Effects of membrane-energy mutations and cations on streptomycin and gentamicin accumulation by bacteria: a model for entry of streptomycin and gentamicin in susceptible and resistant bacteria. Antimicrob Agents Chemother 12 (1977), 163–177.
36. Taber, H.W., Mueller, J.P., Miller, P.F., Arrow, A.S., Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev 51 (1987), 439–457.
37. Lobritz, M.A., et al. Antibiotic efficacy is linked to bacterial cellular respiration. Proc Natl Acad Sci U S A 112 (2015), 8173–8180.
38. Conlon, B.P., et al. Persister formation in Staphylococcus aureus is associated with ATP depletion. Nat Microbiol, 1, 2016, 16051 The authors use fluorescence-activated cell sorting to demonstrate that persister cell formation in Staphylococcus aureus is associated with a stochastic switch to a low ATP, stationary phase-like state.
39. Shan, Y., et al. ATP-dependent persister formation in Escherichia coli. MBio, 8, 2017 The authors use fluorescence-activated cell sorting to demonstrate that persister cell formation in Esherichia coli is associated with entry into a low ATP state with a decreased number of active antibiotic targets.
40. Garcia, L.G., et al. Antibiotic activity against small-colony variants of Staphylococcus aureus: review of in vitro, animal and clinical data. J Antimicrob Chemother 68 (2013), 1455–1464.
41. Painter, K.L., et al. Staphylococcus aureus adapts to oxidative stress by producing H2O2-resistant small-colony variants via the SOS response. Infect Immun 83 (2015), 1830–1844.
42. Leimer, N., et al. Nonstable Staphylococcus aureus small-colony variants are induced by low pH and sensitized to antimicrobial therapy by phagolysosomal alkalinization. J Infect Dis 213 (2016), 305–313.
43. Nguyen, D., et al. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 334 (2011), 982–986.
44. Eng, R.H., Padberg, F.T., Smith, S.M., Tan, E.N., Cherubin, C.E., Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother 35 (1991), 1824–1828.
45. Amato, S.M., Brynildsen, M.P., Nutrient transitions are a source of persisters in Escherichia coli biofilms. PLoS ONE, 9, 2014, e93110.
46. Maisonneuve, E., Castro-Camargo, M., Gerdes, K., (p)ppGpp controls bacterial persistence by stochastic induction of toxin–antitoxin activity. Cell 154 (2013), 1140–1150.
47. Stewart, P.S., Franklin, M.J., Physiological heterogeneity in biofilms. Nat Rev Microbiol 6 (2008), 199–210.
48. Borriello, G., Richards, L., Ehrlich, G.D., Stewart, P.S., Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms. Antimicrob Agents Chemother 50 (2006), 382–384.
49. Waters, E.M., Rowe, S.E., O'Gara, J.P., Conlon, B.P., Convergence of Staphylococcus aureus persister and biofilm research: can biofilms be defined as communities of adherent persister cells?. PLoS Pathog, 12, 2016, e1006012.
50. Conlon, B.P., et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503 (2013), 365–370.